Traveller's diarrhoea vaccine - Intercell
Latest Information Update: 23 Jan 2009
At a glance
- Originator Intercell
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Traveller's diarrhoea
Most Recent Events
- 22 Sep 2006 This vaccine is still in active development